Lv1
70 积分 2025-11-22 加入
Posterior Capsule Opacification: A Review of Experimental Studies
1天前
待确认
160P COLUMBIA-1: A phase Ib/II, open-label, randomized, multicenter study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab as first-line (1L) therapy in metastatic microsatellite-stable colorectal cancer (MSS-mCRC)
3个月前
已关闭
Preliminary safety, pharmacokinetics (PK), pharmacodynamics (PD) and clinical efficacy of uliledlimab (TJ004309), a differentiated CD73 antibody, in combination with atezolizumab in patients with advanced cancer
4个月前
已关闭
皖公网安备34019202002308
